Published in J Virol on November 01, 1981
Leukemogenesis by bovine leukemia virus: proviral DNA integration and lack of RNA expression of viral long terminal repeat and 3' proximate cellular sequences. Proc Natl Acad Sci U S A (1982) 2.02
Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human. Retrovirology (2007) 1.71
Transcriptional activation of bovine leukemia virus in blood cells from experimentally infected, asymptomatic sheep with latent infections. J Virol (1989) 1.42
Bovine leukemia virus: unique structural features of its long terminal repeats and its evolutionary relationship to human T-cell leukemia virus. Proc Natl Acad Sci U S A (1984) 1.37
Sequence variability of bovine leukemia virus env gene and its relevance to the structure and antigenicity of the glycoproteins. J Virol (1990) 1.29
In vivo transcription of the bovine leukemia virus tax/rex region in normal and neoplastic lymphocytes of cattle and sheep. J Virol (1991) 1.26
The prevalence of proviral bovine leukemia virus in peripheral blood mononuclear cells at two subclinical stages of infection. J Virol (1996) 1.19
Even transcriptionally competent proviruses are silent in bovine leukemia virus-induced sheep tumor cells. Proc Natl Acad Sci U S A (1988) 1.19
Chromosome integration domain for bovine leukemia provirus in tumors. J Virol (1983) 1.16
Identification and some biochemical properties of the major XBL gene product of bovine leukemia virus. Proc Natl Acad Sci U S A (1985) 1.14
Role of the 3' long open reading frame region of bovine leukemia virus in the maintenance of cell transformation. J Virol (1985) 1.13
The 3' region of bovine leukemia virus genome encodes a trans-activator protein. EMBO J (1986) 1.08
Involvement of the cyclic AMP-responsive element binding protein in bovine leukemia virus expression in vivo. J Virol (1994) 1.07
The pX region of the bovine leukemia virus is transcribed as a 2.1-kilobase mRNA. J Virol (1985) 1.06
Expression of the bovine leukemia virus X region in virus-infected cells. J Virol (1987) 1.05
Comparison of the entire genomes of bovine leukemia virus and human T-cell leukemia virus and characterization of their unidentified open reading frames. EMBO J (1984) 1.02
Nucleotide sequence analysis of the long terminal repeat of integrated bovine leukemia provirus DNA and of adjacent viral and host sequences. J Virol (1984) 1.00
Inhibition of protein kinase C results in decreased expression of bovine leukemia virus. J Virol (1992) 0.95
Episodic occurrence of antibodies against the bovine leukemia virus Rex protein during the course of infection in sheep. J Virol (1991) 0.91
Activator-dependent and activator-independent defective recombinant retroviruses from bovine leukemia virus. J Virol (1991) 0.89
Peripheral blood mononuclear cells from sheep infected with a variant of bovine leukemia virus synthesize envelope glycoproteins but fail to induce syncytia in culture. J Virol (1996) 0.87
Molecular cloning of covalently closed circular DNA of bovine leukemia virus. J Virol (1984) 0.83
Amplification and analysis of specific DNA and RNA sequences of bovine leukemia virus from infected cows by polymerase chain reaction. J Clin Microbiol (1992) 0.83
Dileucine and YXXL motifs in the cytoplasmic tail of the bovine leukemia virus transmembrane envelope protein affect protein expression on the cell surface. J Virol (2004) 0.78
Characterization of cellular sequences flanking an integrated bovine leukemia virus genome. J Virol (1984) 0.75
Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol (1977) 205.11
The isolation of structural genes from libraries of eucaryotic DNA. Cell (1978) 37.13
Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis. Nature (1981) 17.31
A new class of murine leukemia virus associated with development of spontaneous lymphomas. Proc Natl Acad Sci U S A (1977) 13.96
EK2 derivatives of bacteriophage lambda useful in the cloning of DNA from higher organisms: the lambdagtWES system. Science (1977) 13.24
Avian leukosis virus-induced tumors have common proviral integration sites and synthesize discrete new RNAs: oncogenesis by promoter insertion. Cell (1981) 8.69
Cloning human fetal gamma globin and mouse alpha-type globin DNA: preparation and screening of shotgun collections. Science (1978) 8.24
Analysis of avian leukosis virus DNA and RNA in bursal tumours: viral gene expression is not required for maintenance of the tumor state. Cell (1981) 6.98
Three new types of viral oncogene of cellular origin specific for haematopoietic cell transformation. Nature (1979) 5.75
Structure of the Abelson murine leukemia virus genome. Cell (1979) 2.27
Organization of the endogenous proviruses of chickens: implications for origin and expression. Virology (1981) 1.68
Genomic integration of bovine leukemia provirus: comparison of persistent lymphocytosis with lymph node tumor form of enzootic. Proc Natl Acad Sci U S A (1980) 1.61
Amino-terminal sequence of bovine leukemia virus major internal protein: homology with mammalian type C virus p30 structural proteins. Proc Natl Acad Sci U S A (1979) 1.57
A rapid method for extracting DNA from agarose gels. Plasmid (1978) 1.37
Restriction endonuclease mapping of linear unintegrated proviral DNA of bovine leukemia virus. J Virol (1981) 1.24
Integration of bovine leukemia virus DNA in the bovine genome. Proc Natl Acad Sci U S A (1979) 1.23
Purification of the DNA polymerase of avian myeloblastosis virus. Biochim Biophys Acta (1971) 6.64
Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev (1994) 6.10
Characterization of the products of DNA-directed DNA polymerases in oncogenic RNA viruses. Nature (1970) 5.23
Mating signals control expression of mutations resulting from insertion of a transposable repetitive element adjacent to diverse yeast genes. Cell (1980) 5.20
DNA-directed DNA polymerase activity in oncogenic RNA viruses. Nature (1970) 4.81
Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions. Science (1986) 4.04
Synthetic DNA-RNA hybrids and RNA-RNA duplexes as templates for the polymerases of the oncogenic RNA viruses. Nature (1970) 3.98
Translational blockade imposed by cytokine-derived UA-rich sequences. Science (1989) 3.68
The GAG precursor of simian immunodeficiency virus assembles into virus-like particles. EMBO J (1989) 3.50
HIV-1 tat transcriptional activity is regulated by acetylation. EMBO J (1999) 3.10
The gag and pol genes of bovine leukemia virus: nucleotide sequence and analysis. Virology (1985) 2.53
Identification of a transcriptional enhancer element upstream from the proto-oncogene fos. Science (1985) 2.39
Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. Genomics (1996) 2.34
[Isolation of messenger RNA from rabbit reticulocytes]. Biochim Biophys Acta (1965) 2.25
The neurotrophic factor neuroleukin is 90% homologous with phosphohexose isomerase. Nature (1988) 2.16
The Polycomb-group homolog Bmi-1 is a regulator of murine Hox gene expression. Mech Dev (1996) 2.13
Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine. J Virol (1996) 2.12
Leukemogenesis by bovine leukemia virus: proviral DNA integration and lack of RNA expression of viral long terminal repeat and 3' proximate cellular sequences. Proc Natl Acad Sci U S A (1982) 2.02
Bovine leukemia virus: an exogenous RNA oncogenic virus. Proc Natl Acad Sci U S A (1976) 2.01
The nucleotide sequence of the env gene and post-env region of bovine leukemia virus. Virology (1984) 1.98
Class IIa histone deacetylases: regulating the regulators. Oncogene (2007) 1.78
In vivo infection of sheep by bovine leukemia virus mutants. J Virol (1993) 1.69
Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS. Proc Natl Acad Sci U S A (1998) 1.68
DNA polymerase activities in varions of visna virus, a causative agent of a "slow" neurological disease. Proc Natl Acad Sci U S A (1971) 1.67
Trans activation of the bovine leukemia virus long terminal repeat in BLV-infected cells. Science (1985) 1.67
Use of two monoclonal antibodies in an ELISA test for the detection of antibodies to bovine leukaemia virus envelope protein gp51. J Virol Methods (1989) 1.66
Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine. J Hum Virol (1999) 1.65
Genomic integration of bovine leukemia provirus: comparison of persistent lymphocytosis with lymph node tumor form of enzootic. Proc Natl Acad Sci U S A (1980) 1.61
Translation of bovine leukemia virus virion RNAs in heterologous protein-synthesizing systems. J Virol (1979) 1.60
Isolation and characterization of a 2.3-kilobase-pair cDNA fragment encoding the binding domain of the bovine leukemia virus cell receptor. J Virol (1993) 1.58
C-C chemokines, pivotal in protection against HIV type 1 infection. Proc Natl Acad Sci U S A (1998) 1.57
An immunophilin that binds M(r) 90,000 heat shock protein: main structural features of a mammalian p59 protein. Proc Natl Acad Sci U S A (1992) 1.56
Characterization of the messenger ribonucleoprotein released from reticulocyte polyribosomes by EDTA treatment. Eur J Biochem (1971) 1.56
Genomic integration of bovine leukemia provirus and lack of viral RNA expression in the target cells of cattle with different responses to BLV infection. Leuk Res (1980) 1.53
Assembly of the matrix protein of simian immunodeficiency virus into virus-like particles. Virology (1993) 1.52
Absence of polyadenylate segment in globin messenger RNA accelerates its degradation in Xenopus oocytes. Proc Natl Acad Sci U S A (1975) 1.51
The bovine leukemia virus p34 is a transactivator protein. EMBO J (1987) 1.48
Cooperation between bovine leukaemia virus transactivator protein and Ha-ras oncogene product in cellular transformation. EMBO J (1990) 1.44
Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques. Proc Natl Acad Sci U S A (2000) 1.42
Transducing positional information to the Hox genes: critical interaction of cdx gene products with position-sensitive regulatory elements. Development (1998) 1.40
Isolation of the mouse mammary tumor virus sequences not transmitted as germinal provirus in the C3H and RIII mouse strains. J Virol (1977) 1.39
Bovine leukemia virus, an animal model for the study of intrastrain variability. J Virol (1993) 1.38
Safety and immunogenicity of HIV-1 Tat toxoid in immunocompromised HIV-1-infected patients. J Hum Virol (1999) 1.38
Evolution of microRNA expression during human bronchial squamous carcinogenesis. Eur Respir J (2008) 1.35
Release of messenger RNA from rabbit reticulocyte polyribosomes at low concentration of divalent cations. Biochim Biophys Acta (1967) 1.35
Ectopic expression of Hoxb-8 causes duplication of the ZPA in the forelimb and homeotic transformation of axial structures. Cell (1994) 1.34
Attenuation of bovine leukemia virus by deletion of R3 and G4 open reading frames. Proc Natl Acad Sci U S A (1994) 1.31
Mutations located on both F1 and F2 subunits of the Newcastle disease virus fusion protein confer resistance to neutralization with monoclonal antibodies. J Virol (1989) 1.30
L-Ornithine transaminase synthesis in Saccharomyces cerevisiae: regulation by inducer exclusion. Mol Gen Genet (1979) 1.30
Differential transcriptional activation by human T-cell leukemia virus type 1 Tax mutants is mediated by distinct interactions with CREB binding protein and p300. Mol Cell Biol (1998) 1.30
Bovine leukaemia: facts and hypotheses derived from the study of an infectious cancer. Cancer Surv (1987) 1.29
Sequence variability of bovine leukemia virus env gene and its relevance to the structure and antigenicity of the glycoproteins. J Virol (1990) 1.29
Recombinant vaccinia virus expression of the bovine leukaemia virus envelope gene and protection of immunized sheep against infection. Vaccine (1991) 1.28
The human T-cell leukemia virus type 1 transactivator protein Tax colocalizes in unique nuclear structures with NF-kappaB proteins. J Virol (1997) 1.28
A transcriptional regulatory element is associated with a nuclease-hypersensitive site in the pol gene of human immunodeficiency virus type 1. J Virol (1994) 1.26
In vivo transfection of bovine leukemia provirus into sheep. Virology (1992) 1.25
Humoral antibody response to bovine leukemia virus infection in cattle and sheep. Cancer Res (1979) 1.24
Thermosensitive mutations affecting ribonucleic acid polymerases in Saccharomyces cerevisiae. J Bacteriol (1976) 1.24
Restriction endonuclease mapping of linear unintegrated proviral DNA of bovine leukemia virus. J Virol (1981) 1.24
Bovine leukaemia: facts and hypotheses derived from the study of an infectious cancer. Vet Microbiol (1988) 1.23
Integration of bovine leukemia virus DNA in the bovine genome. Proc Natl Acad Sci U S A (1979) 1.23
Goat lymphosarcoma from bovine leukemia virus. J Natl Cancer Inst (1981) 1.22
A mouse homeobox containing gene on chromosome 11: sequence and tissue-specific expression. Nucleic Acids Res (1987) 1.21
Active anti-interferon-alpha immunization: a European-Israeli, randomized, double-blind, placebo-controlled clinical trial in 242 HIV-1--infected patients (the EURIS study). J Acquir Immune Defic Syndr Hum Retrovirol (1999) 1.20
Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma. Eur Respir J (1999) 1.20
Axial skeletal patterning in mice lacking all paralogous group 8 Hox genes. Development (2001) 1.20
Even transcriptionally competent proviruses are silent in bovine leukemia virus-induced sheep tumor cells. Proc Natl Acad Sci U S A (1988) 1.19
The YXXL signalling motifs of the bovine leukemia virus transmembrane protein are required for in vivo infection and maintenance of high viral loads. J Virol (1995) 1.18
Genetic determinants of bovine leukemia virus pathogenesis. AIDS Res Hum Retroviruses (2000) 1.16
Separation of the messenger RNA of reticulocyte polyribosomes. Biochem Biophys Res Commun (1964) 1.16
Chromosome integration domain for bovine leukemia provirus in tumors. J Virol (1983) 1.16
Fusogenic segments of bovine leukemia virus and simian immunodeficiency virus are interchangeable and mediate fusion by means of oblique insertion in the lipid bilayer of their target cells. Proc Natl Acad Sci U S A (1992) 1.16
A cyclic AMP-responsive DNA-binding protein (CREB2) is a cellular transactivator of the bovine leukemia virus long terminal repeat. J Virol (1992) 1.15
Bovine leukemia virus. Curr Top Microbiol Immunol (1984) 1.15